サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1399199

世界の肝炎B治療口唇の薬市場：考察と予測 (2030年まで)

Global Hepatitis B Treatment Oral Medicine Market Insights, Forecast to 2030
出版日: | 発行: QYResearch | ページ情報: 英文 116 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
世界の肝炎B治療口唇の薬市場：考察と予測 (2030年まで)
出版日: 2023年12月26日
発行: QYResearch
ページ情報: 英文 116 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、肝炎B治療口唇の薬 (Hepatitis B Treatment Oral Medicine) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • 肝炎B治療口唇の薬の製品概要
  • 市場：タイプ別
    • 世界の肝炎B治療口唇の薬の市場規模成長率：タイプ別, 2019 VS 2023 VS 2030
    • Entecavir
    • Tenofovir
    • Lamivudine
    • Adefovir
    • Telbivudine
    • Others
  • 市場：用途別
    • 世界の肝炎B治療口唇の薬の市場規模成長率：用途別, 2019 VS 2023 VS 2030
    • Hospital
    • Clinic
    • Others
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 レポート概要

  • 世界の肝炎B治療口唇の薬売上予測・予想 2019-2030
  • 世界の肝炎B治療口唇の薬の収益：地域別
    • 世界の肝炎B治療口唇の薬の収益：地域別: 2019 VS 2023 VS 2030
    • 世界の肝炎B治療口唇の薬の収益：地域別 (2019-2024)
    • 世界の肝炎B治療口唇の薬の収益：地域別 (2025-2030)
    • 世界の肝炎B治療口唇の薬の収益市場シェア 地域別 (2019-2030)
  • 世界の肝炎B治療口唇の薬売上予測・予想 2019-2030
  • 世界の肝炎B治療口唇の薬の販売：地域別
    • 世界の肝炎B治療口唇の薬の販売：地域別: 2019 VS 2023 VS 2030
    • 世界の肝炎B治療口唇の薬の販売：地域別 (2019-2024)
    • 世界の肝炎B治療口唇の薬の販売：地域別 (2025-2030)
    • 世界の肝炎B治療口唇の薬の販売市場シェア 地域別 (2019-2030)
  • 米国・カナダ
  • 欧州
  • 中国
  • アジア（中国を除く）
  • 中東, アフリカ ・ラテンアメリカ

第3章 競合：企業別

  • 世界の肝炎B治療口唇の薬の販売：企業別
    • 世界の肝炎B治療口唇の薬の販売：企業別 (2019-2024)
    • 世界の肝炎B治療口唇の薬の販売市場シェア：企業別 (2019-2024)
    • 世界の上位10・上位5企業： 肝炎B治療口唇の薬 in 2023
  • 世界の肝炎B治療口唇の薬の収益：企業別
    • 世界の肝炎B治療口唇の薬の収益：企業別 (2019-2024)
    • 世界の肝炎B治療口唇の薬の収益市場シェア：企業別 (2019-2024)
    • 世界の上位10・上位5企業： 肝炎B治療口唇の薬の収益 2023
  • 世界の主要企業 肝炎B治療口唇の薬, 業界ランキング, 2022 VS 2023 VS 2024
  • 世界の肝炎B治療口唇の薬の販売価格：企業別
  • 競合情勢の分析
    • 企業の市場集中度 (CR5 and HHI)
    • 世界の肝炎B治療口唇の薬の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要メーカー 肝炎B治療口唇の薬, 製造拠点分布と本社
  • 世界の主要メーカー 肝炎B治療口唇の薬, 提供製品と用途
  • 世界の主要メーカー 肝炎B治療口唇の薬, 業界参入時期
  • M&A, 拡張計画

第4章 市場規模：タイプ別

  • 世界の肝炎B治療口唇の薬の販売：タイプ別
    • 世界の肝炎B治療口唇の薬の販売実績：タイプ別 (2019-2024)
    • 世界の肝炎B治療口唇の薬の販売予測：タイプ別 (2025-2030)
    • 世界の肝炎B治療口唇の薬の販売市場シェア：タイプ別 (2019-2030)
  • 世界の肝炎B治療口唇の薬 収益：タイプ別
    • 世界の肝炎B治療口唇の薬の収益実績：タイプ別 (2019-2024)
    • 世界の肝炎B治療口唇の薬の収益予測：タイプ別 (2025-2030)
    • 世界の肝炎B治療口唇の薬の収益市場シェア：タイプ別 (2019-2030)
  • 世界の肝炎B治療口唇の薬の価格：タイプ別
    • 世界の肝炎B治療口唇の薬の価格：タイプ別 (2019-2024)
    • 世界の肝炎B治療口唇の薬の価格予測：タイプ別 (2025-2030)

第5章 市場規模：用途別

  • 世界の肝炎B治療口唇の薬の販売：用途別
    • 世界の肝炎B治療口唇の薬の販売実績：用途別 (2019-2024)
    • 世界の肝炎B治療口唇の薬の販売予測：用途別 (2025-2030)
    • 世界の肝炎B治療口唇の薬の販売市場シェア：用途別 (2019-2030)
  • 世界の肝炎B治療口唇の薬の収益：用途別
    • 世界の肝炎B治療口唇の薬の収益実績：用途別 (2019-2024)
    • 世界の肝炎B治療口唇の薬の収益予測：用途別 (2025-2030)
    • 世界の肝炎B治療口唇の薬の収益市場シェア：用途別 (2019-2030)
  • 世界の肝炎B治療口唇の薬の価格：用途別
    • 世界の肝炎B治療口唇の薬の価格：用途別 (2019-2024)
    • 世界の肝炎B治療口唇の薬の価格予測：用途別 (2025-2030)

第6章 米国・カナダ

  • 米国・カナダ 肝炎B治療口唇の薬 市場規模：タイプ別
    • 米国・カナダ 肝炎B治療口唇の薬の販売：タイプ別 (2019-2030)
    • 米国・カナダ 肝炎B治療口唇の薬 収益：タイプ別 (2019-2030)
  • 米国・カナダ 肝炎B治療口唇の薬 市場規模：用途別
    • 米国・カナダ 肝炎B治療口唇の薬の販売：用途別 (2019-2030)
    • 米国・カナダ 肝炎B治療口唇の薬の収益：用途別 (2019-2030)
  • 米国・カナダ 肝炎B治療口唇の薬 市場規模：国別
    • 米国・カナダ 肝炎B治療口唇の薬の収益：国別: 2019 VS 2023 VS 2030
    • 米国・カナダ 肝炎B治療口唇の薬の販売：国別 (2019-2030)
    • 米国・カナダ 肝炎B治療口唇の薬の収益：国別 (2019-2030)
    • US
    • カナダ

第7章 欧州

  • 欧州の肝炎B治療口唇の薬 市場規模：タイプ別
    • 欧州の肝炎B治療口唇の薬の販売：タイプ別 (2019-2030)
    • 欧州の肝炎B治療口唇の薬 収益：タイプ別 (2019-2030)
  • 欧州の肝炎B治療口唇の薬 市場規模：用途別
    • 欧州の肝炎B治療口唇の薬の販売：用途別 (2019-2030)
    • 欧州の肝炎B治療口唇の薬の収益：用途別 (2019-2030)
  • 欧州の肝炎B治療口唇の薬 市場規模：国別
    • 欧州の肝炎B治療口唇の薬の収益：国別: 2019 VS 2023 VS 2030
    • 欧州の肝炎B治療口唇の薬の販売：国別 (2019-2030)
    • 欧州の肝炎B治療口唇の薬の収益：国別 (2019-2030)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 中国

  • 中国の肝炎B治療口唇の薬 市場規模
    • 中国の肝炎B治療口唇の薬 売上 (2019-2030)
    • 中国の肝炎B治療口唇の薬 収益 (2019-2030)
  • 中国の肝炎B治療口唇の薬 市場規模：用途別
    • 中国の肝炎B治療口唇の薬の販売：用途別 (2019-2030)
    • 中国の肝炎B治療口唇の薬の収益：用途別 (2019-2030)

第9章 アジア（中国を除く）

  • アジア地域 肝炎B治療口唇の薬 市場規模：タイプ別
    • アジア地域 肝炎B治療口唇の薬の販売：タイプ別 (2019-2030)
    • アジア地域 肝炎B治療口唇の薬 収益：タイプ別 (2019-2030)
  • アジア地域 肝炎B治療口唇の薬 市場規模：用途別
    • アジア地域 肝炎B治療口唇の薬の販売：用途別 (2019-2030)
    • アジア地域 肝炎B治療口唇の薬の収益：用途別 (2019-2030)
  • アジア地域 肝炎B治療口唇の薬の販売：地域別
    • アジア地域 肝炎B治療口唇の薬の収益：地域別: 2019 VS 2023 VS 2030
    • アジア地域 肝炎B治療口唇の薬の収益：地域別 (2019-2030)
    • アジア地域 肝炎B治療口唇の薬の販売：地域別 (2019-2030)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド

第10章 中東, アフリカ ・ラテンアメリカ

  • 中東, アフリカ ・ラテンアメリカの肝炎B治療口唇の薬 市場規模：タイプ別
    • 中東, アフリカ ・ラテンアメリカの肝炎B治療口唇の薬の販売：タイプ別 (2019-2030)
    • 中東, アフリカ ・ラテンアメリカの肝炎B治療口唇の薬 収益：タイプ別 (2019-2030)
  • 中東, アフリカ ・ラテンアメリカの肝炎B治療口唇の薬 市場規模：用途別
    • 中東, アフリカ ・ラテンアメリカの肝炎B治療口唇の薬の販売：用途別 (2019-2030)
    • 中東, アフリカ ・ラテンアメリカの肝炎B治療口唇の薬の収益：用途別 (2019-2030)
  • 中東, アフリカ ・ラテンアメリカの肝炎B治療口唇の薬の販売：国別
    • 中東, アフリカ ・ラテンアメリカの肝炎B治療口唇の薬の収益：国別: 2019 VS 2023 VS 2030
    • 中東, アフリカ ・ラテンアメリカの肝炎B治療口唇の薬の収益：国別 (2019-2030)
    • 中東, アフリカ ・ラテンアメリカの肝炎B治療口唇の薬の販売：国別 (2019-2030)
    • ブラジル
    • メキシコ
    • トルコ
    • イスラエル
    • 湾岸協力理事会諸国

第11章 企業プロファイル

  • GSK
  • Bristol Myers Squibb
  • Gilead Sciences
  • Novartis
  • Roche
  • Merck
  • Johnson & Johnson
  • Dawnrays Pharmaceutical
  • Hansoh Pharmaceutical
  • Chia Tai-Tianqing Pharmaceutical
  • Qilu pharmaceutical
  • Fujian Cosunter Pharma
  • YaoPharma
  • Qingfeng Pharmaceutical
  • Kelun Pharmaceutical

第12章 業界チェーンと販売チャネルの分析

  • 肝炎B治療口唇の薬 業界チェーン分析
  • 肝炎B治療口唇の薬 主要原材料
    • 主要原材料
    • 原材料の主要サプライヤー
  • 肝炎B治療口唇の薬 生産形態とプロセス
  • 肝炎B治療口唇の薬 販売およびマーケティング
    • 肝炎B治療口唇の薬 販売チャネルs
    • 肝炎B治療口唇の薬 卸業者
  • 肝炎B治療口唇の薬 顧客

第13章 市場動向

  • 肝炎B治療口唇の薬 業界動向
  • 肝炎B治療口唇の薬 市場の促進要因
  • 肝炎B治療口唇の薬 市場の課題
  • 肝炎B治療口唇の薬 市場の抑制要因

第14章 主な調査結果 世界の肝炎B治療口唇の薬の主な市場調査結果

第15章 付録

図表

List of Tables

  • Table 1. Global Hepatitis B Treatment Oral Medicine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
  • Table 2. Major Manufacturers of Entecavir
  • Table 3. Major Manufacturers of Tenofovir
  • Table 4. Major Manufacturers of Lamivudine
  • Table 5. Major Manufacturers of Adefovir
  • Table 6. Major Manufacturers of Telbivudine
  • Table 7. Major Manufacturers of Others
  • Table 8. Global Hepatitis B Treatment Oral Medicine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
  • Table 9. Global Hepatitis B Treatment Oral Medicine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 10. Global Hepatitis B Treatment Oral Medicine Revenue by Region (2019-2024) & (US$ Million)
  • Table 11. Global Hepatitis B Treatment Oral Medicine Revenue by Region (2025-2030) & (US$ Million)
  • Table 12. Global Hepatitis B Treatment Oral Medicine Revenue Market Share by Region (2019-2024)
  • Table 13. Global Hepatitis B Treatment Oral Medicine Revenue Market Share by Region (2025-2030)
  • Table 14. Global Hepatitis B Treatment Oral Medicine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 15. Global Hepatitis B Treatment Oral Medicine Sales by Region (2019-2024) & (K Units)
  • Table 16. Global Hepatitis B Treatment Oral Medicine Sales by Region (2025-2030) & (K Units)
  • Table 17. Global Hepatitis B Treatment Oral Medicine Sales Market Share by Region (2019-2024)
  • Table 18. Global Hepatitis B Treatment Oral Medicine Sales Market Share by Region (2025-2030)
  • Table 19. Global Hepatitis B Treatment Oral Medicine Sales by Manufacturers (2019-2024) & (K Units)
  • Table 20. Global Hepatitis B Treatment Oral Medicine Sales Share by Manufacturers (2019-2024)
  • Table 21. Global Hepatitis B Treatment Oral Medicine Revenue by Manufacturers (2019-2024) & (US$ Million)
  • Table 22. Global Hepatitis B Treatment Oral Medicine Revenue Share by Manufacturers (2019-2024)
  • Table 23. Global Key Players of Hepatitis B Treatment Oral Medicine, Industry Ranking, 2022 VS 2023 VS 2024
  • Table 24. Hepatitis B Treatment Oral Medicine Price by Manufacturers 2019-2024 (US$/Unit)
  • Table 25. Global Hepatitis B Treatment Oral Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 26. Global Hepatitis B Treatment Oral Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Treatment Oral Medicine as of 2023)
  • Table 27. Global Key Manufacturers of Hepatitis B Treatment Oral Medicine, Manufacturing Base Distribution and Headquarters
  • Table 28. Global Key Manufacturers of Hepatitis B Treatment Oral Medicine, Product Offered and Application
  • Table 29. Global Key Manufacturers of Hepatitis B Treatment Oral Medicine, Date of Enter into This Industry
  • Table 30. Mergers & Acquisitions, Expansion Plans
  • Table 31. Global Hepatitis B Treatment Oral Medicine Sales by Type (2019-2024) & (K Units)
  • Table 32. Global Hepatitis B Treatment Oral Medicine Sales by Type (2025-2030) & (K Units)
  • Table 33. Global Hepatitis B Treatment Oral Medicine Sales Share by Type (2019-2024)
  • Table 34. Global Hepatitis B Treatment Oral Medicine Sales Share by Type (2025-2030)
  • Table 35. Global Hepatitis B Treatment Oral Medicine Revenue by Type (2019-2024) & (US$ Million)
  • Table 36. Global Hepatitis B Treatment Oral Medicine Revenue by Type (2025-2030) & (US$ Million)
  • Table 37. Global Hepatitis B Treatment Oral Medicine Revenue Share by Type (2019-2024)
  • Table 38. Global Hepatitis B Treatment Oral Medicine Revenue Share by Type (2025-2030)
  • Table 39. Hepatitis B Treatment Oral Medicine Price by Type (2019-2024) & (US$/Unit)
  • Table 40. Global Hepatitis B Treatment Oral Medicine Price Forecast by Type (2025-2030) & (US$/Unit)
  • Table 41. Global Hepatitis B Treatment Oral Medicine Sales by Application (2019-2024) & (K Units)
  • Table 42. Global Hepatitis B Treatment Oral Medicine Sales by Application (2025-2030) & (K Units)
  • Table 43. Global Hepatitis B Treatment Oral Medicine Sales Share by Application (2019-2024)
  • Table 44. Global Hepatitis B Treatment Oral Medicine Sales Share by Application (2025-2030)
  • Table 45. Global Hepatitis B Treatment Oral Medicine Revenue by Application (2019-2024) & (US$ Million)
  • Table 46. Global Hepatitis B Treatment Oral Medicine Revenue by Application (2025-2030) & (US$ Million)
  • Table 47. Global Hepatitis B Treatment Oral Medicine Revenue Share by Application (2019-2024)
  • Table 48. Global Hepatitis B Treatment Oral Medicine Revenue Share by Application (2025-2030)
  • Table 49. Hepatitis B Treatment Oral Medicine Price by Application (2019-2024) & (US$/Unit)
  • Table 50. Global Hepatitis B Treatment Oral Medicine Price Forecast by Application (2025-2030) & (US$/Unit)
  • Table 51. US & Canada Hepatitis B Treatment Oral Medicine Sales by Type (2019-2024) & (K Units)
  • Table 52. US & Canada Hepatitis B Treatment Oral Medicine Sales by Type (2025-2030) & (K Units)
  • Table 53. US & Canada Hepatitis B Treatment Oral Medicine Revenue by Type (2019-2024) & (US$ Million)
  • Table 54. US & Canada Hepatitis B Treatment Oral Medicine Revenue by Type (2025-2030) & (US$ Million)
  • Table 55. US & Canada Hepatitis B Treatment Oral Medicine Sales by Application (2019-2024) & (K Units)
  • Table 56. US & Canada Hepatitis B Treatment Oral Medicine Sales by Application (2025-2030) & (K Units)
  • Table 57. US & Canada Hepatitis B Treatment Oral Medicine Revenue by Application (2019-2024) & (US$ Million)
  • Table 58. US & Canada Hepatitis B Treatment Oral Medicine Revenue by Application (2025-2030) & (US$ Million)
  • Table 59. US & Canada Hepatitis B Treatment Oral Medicine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 60. US & Canada Hepatitis B Treatment Oral Medicine Revenue by Country (2019-2024) & (US$ Million)
  • Table 61. US & Canada Hepatitis B Treatment Oral Medicine Revenue by Country (2025-2030) & (US$ Million)
  • Table 62. US & Canada Hepatitis B Treatment Oral Medicine Sales by Country (2019-2024) & (K Units)
  • Table 63. US & Canada Hepatitis B Treatment Oral Medicine Sales by Country (2025-2030) & (K Units)
  • Table 64. Europe Hepatitis B Treatment Oral Medicine Sales by Type (2019-2024) & (K Units)
  • Table 65. Europe Hepatitis B Treatment Oral Medicine Sales by Type (2025-2030) & (K Units)
  • Table 66. Europe Hepatitis B Treatment Oral Medicine Revenue by Type (2019-2024) & (US$ Million)
  • Table 67. Europe Hepatitis B Treatment Oral Medicine Revenue by Type (2025-2030) & (US$ Million)
  • Table 68. Europe Hepatitis B Treatment Oral Medicine Sales by Application (2019-2024) & (K Units)
  • Table 69. Europe Hepatitis B Treatment Oral Medicine Sales by Application (2025-2030) & (K Units)
  • Table 70. Europe Hepatitis B Treatment Oral Medicine Revenue by Application (2019-2024) & (US$ Million)
  • Table 71. Europe Hepatitis B Treatment Oral Medicine Revenue by Application (2025-2030) & (US$ Million)
  • Table 72. Europe Hepatitis B Treatment Oral Medicine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 73. Europe Hepatitis B Treatment Oral Medicine Revenue by Country (2019-2024) & (US$ Million)
  • Table 74. Europe Hepatitis B Treatment Oral Medicine Revenue by Country (2025-2030) & (US$ Million)
  • Table 75. Europe Hepatitis B Treatment Oral Medicine Sales by Country (2019-2024) & (K Units)
  • Table 76. Europe Hepatitis B Treatment Oral Medicine Sales by Country (2025-2030) & (K Units)
  • Table 77. China Hepatitis B Treatment Oral Medicine Sales by Type (2019-2024) & (K Units)
  • Table 78. China Hepatitis B Treatment Oral Medicine Sales by Type (2025-2030) & (K Units)
  • Table 79. China Hepatitis B Treatment Oral Medicine Revenue by Type (2019-2024) & (US$ Million)
  • Table 80. China Hepatitis B Treatment Oral Medicine Revenue by Type (2025-2030) & (US$ Million)
  • Table 81. China Hepatitis B Treatment Oral Medicine Sales by Application (2019-2024) & (K Units)
  • Table 82. China Hepatitis B Treatment Oral Medicine Sales by Application (2025-2030) & (K Units)
  • Table 83. China Hepatitis B Treatment Oral Medicine Revenue by Application (2019-2024) & (US$ Million)
  • Table 84. China Hepatitis B Treatment Oral Medicine Revenue by Application (2025-2030) & (US$ Million)
  • Table 85. Asia Hepatitis B Treatment Oral Medicine Sales by Type (2019-2024) & (K Units)
  • Table 86. Asia Hepatitis B Treatment Oral Medicine Sales by Type (2025-2030) & (K Units)
  • Table 87. Asia Hepatitis B Treatment Oral Medicine Revenue by Type (2019-2024) & (US$ Million)
  • Table 88. Asia Hepatitis B Treatment Oral Medicine Revenue by Type (2025-2030) & (US$ Million)
  • Table 89. Asia Hepatitis B Treatment Oral Medicine Sales by Application (2019-2024) & (K Units)
  • Table 90. Asia Hepatitis B Treatment Oral Medicine Sales by Application (2025-2030) & (K Units)
  • Table 91. Asia Hepatitis B Treatment Oral Medicine Revenue by Application (2019-2024) & (US$ Million)
  • Table 92. Asia Hepatitis B Treatment Oral Medicine Revenue by Application (2025-2030) & (US$ Million)
  • Table 93. Asia Hepatitis B Treatment Oral Medicine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 94. Asia Hepatitis B Treatment Oral Medicine Revenue by Region (2019-2024) & (US$ Million)
  • Table 95. Asia Hepatitis B Treatment Oral Medicine Revenue by Region (2025-2030) & (US$ Million)
  • Table 96. Asia Hepatitis B Treatment Oral Medicine Sales by Region (2019-2024) & (K Units)
  • Table 97. Asia Hepatitis B Treatment Oral Medicine Sales by Region (2025-2030) & (K Units)
  • Table 98. Middle East, Africa and Latin America Hepatitis B Treatment Oral Medicine Sales by Type (2019-2024) & (K Units)
  • Table 99. Middle East, Africa and Latin America Hepatitis B Treatment Oral Medicine Sales by Type (2025-2030) & (K Units)
  • Table 100. Middle East, Africa and Latin America Hepatitis B Treatment Oral Medicine Revenue by Type (2019-2024) & (US$ Million)
  • Table 101. Middle East, Africa and Latin America Hepatitis B Treatment Oral Medicine Revenue by Type (2025-2030) & (US$ Million)
  • Table 102. Middle East, Africa and Latin America Hepatitis B Treatment Oral Medicine Sales by Application (2019-2024) & (K Units)
  • Table 103. Middle East, Africa and Latin America Hepatitis B Treatment Oral Medicine Sales by Application (2025-2030) & (K Units)
  • Table 104. Middle East, Africa and Latin America Hepatitis B Treatment Oral Medicine Revenue by Application (2019-2024) & (US$ Million)
  • Table 105. Middle East, Africa and Latin America Hepatitis B Treatment Oral Medicine Revenue by Application (2025-2030) & (US$ Million)
  • Table 106. Middle East, Africa and Latin America Hepatitis B Treatment Oral Medicine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 107. Middle East, Africa and Latin America Hepatitis B Treatment Oral Medicine Revenue by Country (2019-2024) & (US$ Million)
  • Table 108. Middle East, Africa and Latin America Hepatitis B Treatment Oral Medicine Revenue by Country (2025-2030) & (US$ Million)
  • Table 109. Middle East, Africa and Latin America Hepatitis B Treatment Oral Medicine Sales by Country (2019-2024) & (K Units)
  • Table 110. Middle East, Africa and Latin America Hepatitis B Treatment Oral Medicine Sales by Country (2025-2030) & (K Units)
  • Table 111. GSK Company Information
  • Table 112. GSK Description and Major Businesses
  • Table 113. GSK Hepatitis B Treatment Oral Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 114. GSK Hepatitis B Treatment Oral Medicine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 115. GSK Recent Developments
  • Table 116. Bristol Myers Squibb Company Information
  • Table 117. Bristol Myers Squibb Description and Major Businesses
  • Table 118. Bristol Myers Squibb Hepatitis B Treatment Oral Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 119. Bristol Myers Squibb Hepatitis B Treatment Oral Medicine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 120. Bristol Myers Squibb Recent Developments
  • Table 121. Gilead Sciences Company Information
  • Table 122. Gilead Sciences Description and Major Businesses
  • Table 123. Gilead Sciences Hepatitis B Treatment Oral Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 124. Gilead Sciences Hepatitis B Treatment Oral Medicine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 125. Gilead Sciences Recent Developments
  • Table 126. Novartis Company Information
  • Table 127. Novartis Description and Major Businesses
  • Table 128. Novartis Hepatitis B Treatment Oral Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 129. Novartis Hepatitis B Treatment Oral Medicine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 130. Novartis Recent Developments
  • Table 131. Roche Company Information
  • Table 132. Roche Description and Major Businesses
  • Table 133. Roche Hepatitis B Treatment Oral Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 134. Roche Hepatitis B Treatment Oral Medicine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 135. Roche Recent Developments
  • Table 136. Merck Company Information
  • Table 137. Merck Description and Major Businesses
  • Table 138. Merck Hepatitis B Treatment Oral Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 139. Merck Hepatitis B Treatment Oral Medicine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 140. Merck Recent Developments
  • Table 141. Johnson & Johnson Company Information
  • Table 142. Johnson & Johnson Description and Major Businesses
  • Table 143. Johnson & Johnson Hepatitis B Treatment Oral Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 144. Johnson & Johnson Hepatitis B Treatment Oral Medicine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 145. Johnson & Johnson Recent Developments
  • Table 146. Dawnrays Pharmaceutical Company Information
  • Table 147. Dawnrays Pharmaceutical Description and Major Businesses
  • Table 148. Dawnrays Pharmaceutical Hepatitis B Treatment Oral Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 149. Dawnrays Pharmaceutical Hepatitis B Treatment Oral Medicine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 150. Dawnrays Pharmaceutical Recent Developments
  • Table 151. Hansoh Pharmaceutical Company Information
  • Table 152. Hansoh Pharmaceutical Description and Major Businesses
  • Table 153. Hansoh Pharmaceutical Hepatitis B Treatment Oral Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 154. Hansoh Pharmaceutical Hepatitis B Treatment Oral Medicine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 155. Hansoh Pharmaceutical Recent Developments
  • Table 156. Chia Tai-Tianqing Pharmaceutical Company Information
  • Table 157. Chia Tai-Tianqing Pharmaceutical Description and Major Businesses
  • Table 158. Chia Tai-Tianqing Pharmaceutical Hepatitis B Treatment Oral Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 159. Chia Tai-Tianqing Pharmaceutical Hepatitis B Treatment Oral Medicine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 160. Chia Tai-Tianqing Pharmaceutical Recent Developments
  • Table 161. Qilu pharmaceutical Company Information
  • Table 162. Qilu pharmaceutical Description and Major Businesses
  • Table 163. Qilu pharmaceutical Hepatitis B Treatment Oral Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 164. Qilu pharmaceutical Hepatitis B Treatment Oral Medicine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 165. Qilu pharmaceutical Recent Developments
  • Table 166. Fujian Cosunter Pharma Company Information
  • Table 167. Fujian Cosunter Pharma Description and Major Businesses
  • Table 168. Fujian Cosunter Pharma Hepatitis B Treatment Oral Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 169. Fujian Cosunter Pharma Hepatitis B Treatment Oral Medicine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 170. Fujian Cosunter Pharma Recent Developments
  • Table 171. YaoPharma Company Information
  • Table 172. YaoPharma Description and Major Businesses
  • Table 173. YaoPharma Hepatitis B Treatment Oral Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 174. YaoPharma Hepatitis B Treatment Oral Medicine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 175. YaoPharma Recent Developments
  • Table 176. Qingfeng Pharmaceutical Company Information
  • Table 177. Qingfeng Pharmaceutical Description and Major Businesses
  • Table 178. Qingfeng Pharmaceutical Hepatitis B Treatment Oral Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 179. Qingfeng Pharmaceutical Hepatitis B Treatment Oral Medicine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 180. Qingfeng Pharmaceutical Recent Developments
  • Table 181. Kelun Pharmaceutical Company Information
  • Table 182. Kelun Pharmaceutical Description and Major Businesses
  • Table 183. Kelun Pharmaceutical Hepatitis B Treatment Oral Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 184. Kelun Pharmaceutical Hepatitis B Treatment Oral Medicine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 185. Kelun Pharmaceutical Recent Developments
  • Table 186. Key Raw Materials Lists
  • Table 187. Raw Materials Key Suppliers Lists
  • Table 188. Hepatitis B Treatment Oral Medicine Distributors List
  • Table 189. Hepatitis B Treatment Oral Medicine Customers List
  • Table 190. Hepatitis B Treatment Oral Medicine Market Trends
  • Table 191. Hepatitis B Treatment Oral Medicine Market Drivers
  • Table 192. Hepatitis B Treatment Oral Medicine Market Challenges
  • Table 193. Hepatitis B Treatment Oral Medicine Market Restraints
  • Table 194. Research Programs/Design for This Report
  • Table 195. Key Data Information from Secondary Sources
  • Table 196. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Hepatitis B Treatment Oral Medicine Product Picture
  • Figure 2. Global Hepatitis B Treatment Oral Medicine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
  • Figure 3. Global Hepatitis B Treatment Oral Medicine Market Share by Type in 2023 & 2030
  • Figure 4. Entecavir Product Picture
  • Figure 5. Tenofovir Product Picture
  • Figure 6. Lamivudine Product Picture
  • Figure 7. Adefovir Product Picture
  • Figure 8. Telbivudine Product Picture
  • Figure 9. Others Product Picture
  • Figure 10. Global Hepatitis B Treatment Oral Medicine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
  • Figure 11. Global Hepatitis B Treatment Oral Medicine Market Share by Application in 2023 & 2030
  • Figure 12. Hospital
  • Figure 13. Clinic
  • Figure 14. Others
  • Figure 15. Hepatitis B Treatment Oral Medicine Report Years Considered
  • Figure 16. Global Hepatitis B Treatment Oral Medicine Revenue, (US$ Million), 2019 VS 2023 VS 2030
  • Figure 17. Global Hepatitis B Treatment Oral Medicine Revenue 2019-2030 (US$ Million)
  • Figure 18. Global Hepatitis B Treatment Oral Medicine Revenue Market Share by Region in Percentage: 2023 Versus 2030
  • Figure 19. Global Hepatitis B Treatment Oral Medicine Revenue Market Share by Region (2019-2030)
  • Figure 20. Global Hepatitis B Treatment Oral Medicine Sales 2019-2030 ((K Units)
  • Figure 21. Global Hepatitis B Treatment Oral Medicine Sales Market Share by Region (2019-2030)
  • Figure 22. US & Canada Hepatitis B Treatment Oral Medicine Sales YoY (2019-2030) & (K Units)
  • Figure 23. US & Canada Hepatitis B Treatment Oral Medicine Revenue YoY (2019-2030) & (US$ Million)
  • Figure 24. Europe Hepatitis B Treatment Oral Medicine Sales YoY (2019-2030) & (K Units)
  • Figure 25. Europe Hepatitis B Treatment Oral Medicine Revenue YoY (2019-2030) & (US$ Million)
  • Figure 26. China Hepatitis B Treatment Oral Medicine Sales YoY (2019-2030) & (K Units)
  • Figure 27. China Hepatitis B Treatment Oral Medicine Revenue YoY (2019-2030) & (US$ Million)
  • Figure 28. Asia (excluding China) Hepatitis B Treatment Oral Medicine Sales YoY (2019-2030) & (K Units)
  • Figure 29. Asia (excluding China) Hepatitis B Treatment Oral Medicine Revenue YoY (2019-2030) & (US$ Million)
  • Figure 30. Middle East, Africa and Latin America Hepatitis B Treatment Oral Medicine Sales YoY (2019-2030) & (K Units)
  • Figure 31. Middle East, Africa and Latin America Hepatitis B Treatment Oral Medicine Revenue YoY (2019-2030) & (US$ Million)
  • Figure 32. The Hepatitis B Treatment Oral Medicine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
  • Figure 33. The Top 5 and 10 Largest Manufacturers of Hepatitis B Treatment Oral Medicine in the World: Market Share by Hepatitis B Treatment Oral Medicine Revenue in 2023
  • Figure 34. Global Hepatitis B Treatment Oral Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
  • Figure 35. Global Hepatitis B Treatment Oral Medicine Sales Market Share by Type (2019-2030)
  • Figure 36. Global Hepatitis B Treatment Oral Medicine Revenue Market Share by Type (2019-2030)
  • Figure 37. Global Hepatitis B Treatment Oral Medicine Sales Market Share by Application (2019-2030)
  • Figure 38. Global Hepatitis B Treatment Oral Medicine Revenue Market Share by Application (2019-2030)
  • Figure 39. US & Canada Hepatitis B Treatment Oral Medicine Sales Market Share by Type (2019-2030)
  • Figure 40. US & Canada Hepatitis B Treatment Oral Medicine Revenue Market Share by Type (2019-2030)
  • Figure 41. US & Canada Hepatitis B Treatment Oral Medicine Sales Market Share by Application (2019-2030)
  • Figure 42. US & Canada Hepatitis B Treatment Oral Medicine Revenue Market Share by Application (2019-2030)
  • Figure 43. US & Canada Hepatitis B Treatment Oral Medicine Revenue Share by Country (2019-2030)
  • Figure 44. US & Canada Hepatitis B Treatment Oral Medicine Sales Share by Country (2019-2030)
  • Figure 45. U.S. Hepatitis B Treatment Oral Medicine Revenue (2019-2030) & (US$ Million)
  • Figure 46. Canada Hepatitis B Treatment Oral Medicine Revenue (2019-2030) & (US$ Million)
  • Figure 47. Europe Hepatitis B Treatment Oral Medicine Sales Market Share by Type (2019-2030)
  • Figure 48. Europe Hepatitis B Treatment Oral Medicine Revenue Market Share by Type (2019-2030)
  • Figure 49. Europe Hepatitis B Treatment Oral Medicine Sales Market Share by Application (2019-2030)
  • Figure 50. Europe Hepatitis B Treatment Oral Medicine Revenue Market Share by Application (2019-2030)
  • Figure 51. Europe Hepatitis B Treatment Oral Medicine Revenue Share by Country (2019-2030)
  • Figure 52. Europe Hepatitis B Treatment Oral Medicine Sales Share by Country (2019-2030)
  • Figure 53. Germany Hepatitis B Treatment Oral Medicine Revenue (2019-2030) & (US$ Million)
  • Figure 54. France Hepatitis B Treatment Oral Medicine Revenue (2019-2030) & (US$ Million)
  • Figure 55. U.K. Hepatitis B Treatment Oral Medicine Revenue (2019-2030) & (US$ Million)
  • Figure 56. Italy Hepatitis B Treatment Oral Medicine Revenue (2019-2030) & (US$ Million)
  • Figure 57. Russia Hepatitis B Treatment Oral Medicine Revenue (2019-2030) & (US$ Million)
  • Figure 58. China Hepatitis B Treatment Oral Medicine Sales Market Share by Type (2019-2030)
  • Figure 59. China Hepatitis B Treatment Oral Medicine Revenue Market Share by Type (2019-2030)
  • Figure 60. China Hepatitis B Treatment Oral Medicine Sales Market Share by Application (2019-2030)
  • Figure 61. China Hepatitis B Treatment Oral Medicine Revenue Market Share by Application (2019-2030)
  • Figure 62. Asia Hepatitis B Treatment Oral Medicine Sales Market Share by Type (2019-2030)
  • Figure 63. Asia Hepatitis B Treatment Oral Medicine Revenue Market Share by Type (2019-2030)
  • Figure 64. Asia Hepatitis B Treatment Oral Medicine Sales Market Share by Application (2019-2030)
  • Figure 65. Asia Hepatitis B Treatment Oral Medicine Revenue Market Share by Application (2019-2030)
  • Figure 66. Asia Hepatitis B Treatment Oral Medicine Revenue Share by Region (2019-2030)
  • Figure 67. Asia Hepatitis B Treatment Oral Medicine Sales Share by Region (2019-2030)
  • Figure 68. Japan Hepatitis B Treatment Oral Medicine Revenue (2019-2030) & (US$ Million)
  • Figure 69. South Korea Hepatitis B Treatment Oral Medicine Revenue (2019-2030) & (US$ Million)
  • Figure 70. China Taiwan Hepatitis B Treatment Oral Medicine Revenue (2019-2030) & (US$ Million)
  • Figure 71. Southeast Asia Hepatitis B Treatment Oral Medicine Revenue (2019-2030) & (US$ Million)
  • Figure 72. India Hepatitis B Treatment Oral Medicine Revenue (2019-2030) & (US$ Million)
  • Figure 73. Middle East, Africa and Latin America Hepatitis B Treatment Oral Medicine Sales Market Share by Type (2019-2030)
  • Figure 74. Middle East, Africa and Latin America Hepatitis B Treatment Oral Medicine Revenue Market Share by Type (2019-2030)
  • Figure 75. Middle East, Africa and Latin America Hepatitis B Treatment Oral Medicine Sales Market Share by Application (2019-2030)
  • Figure 76. Middle East, Africa and Latin America Hepatitis B Treatment Oral Medicine Revenue Market Share by Application (2019-2030)
  • Figure 77. Middle East, Africa and Latin America Hepatitis B Treatment Oral Medicine Revenue Share by Country (2019-2030)
  • Figure 78. Middle East, Africa and Latin America Hepatitis B Treatment Oral Medicine Sales Share by Country (2019-2030)
  • Figure 79. Brazil Hepatitis B Treatment Oral Medicine Revenue (2019-2030) & (US$ Million)
  • Figure 80. Mexico Hepatitis B Treatment Oral Medicine Revenue (2019-2030) & (US$ Million)
  • Figure 81. Turkey Hepatitis B Treatment Oral Medicine Revenue (2019-2030) & (US$ Million)
  • Figure 82. Israel Hepatitis B Treatment Oral Medicine Revenue (2019-2030) & (US$ Million)
  • Figure 83. GCC Countries Hepatitis B Treatment Oral Medicine Revenue (2019-2030) & (US$ Million)
  • Figure 84. Hepatitis B Treatment Oral Medicine Value Chain
  • Figure 85. Hepatitis B Treatment Oral Medicine Production Process
  • Figure 86. Channels of Distribution
  • Figure 87. Distributors Profiles
  • Figure 88. Bottom-up and Top-down Approaches for This Report
  • Figure 89. Data Triangulation
  • Figure 90. Key Executives Interviewed
目次

This research report focuses on the Hepatitis B Treatment Oral Medicine Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Hepatitis B Treatment Oral Medicine Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Hepatitis B Treatment Oral Medicine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
    • 1.2.2 Entecavir
    • 1.2.3 Tenofovir
    • 1.2.4 Lamivudine
    • 1.2.5 Adefovir
    • 1.2.6 Telbivudine
    • 1.2.7 Others
  • 1.3 Market by Application
    • 1.3.1 Global Hepatitis B Treatment Oral Medicine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
    • 1.3.2 Hospital
    • 1.3.3 Clinic
    • 1.3.4 Others
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Executive Summary

  • 2.1 Global Hepatitis B Treatment Oral Medicine Sales Estimates and Forecasts 2019-2030
  • 2.2 Global Hepatitis B Treatment Oral Medicine Revenue by Region
    • 2.2.1 Global Hepatitis B Treatment Oral Medicine Revenue by Region: 2019 VS 2023 VS 2030
    • 2.2.2 Global Hepatitis B Treatment Oral Medicine Revenue by Region (2019-2024)
    • 2.2.3 Global Hepatitis B Treatment Oral Medicine Revenue by Region (2025-2030)
    • 2.2.4 Global Hepatitis B Treatment Oral Medicine Revenue Market Share by Region (2019-2030)
  • 2.3 Global Hepatitis B Treatment Oral Medicine Sales Estimates and Forecasts 2019-2030
  • 2.4 Global Hepatitis B Treatment Oral Medicine Sales by Region
    • 2.4.1 Global Hepatitis B Treatment Oral Medicine Sales by Region: 2019 VS 2023 VS 2030
    • 2.4.2 Global Hepatitis B Treatment Oral Medicine Sales by Region (2019-2024)
    • 2.4.3 Global Hepatitis B Treatment Oral Medicine Sales by Region (2025-2030)
    • 2.4.4 Global Hepatitis B Treatment Oral Medicine Sales Market Share by Region (2019-2030)
  • 2.5 US & Canada
  • 2.6 Europe
  • 2.7 China
  • 2.8 Asia (excluding China)
  • 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

  • 3.1 Global Hepatitis B Treatment Oral Medicine Sales by Manufacturers
    • 3.1.1 Global Hepatitis B Treatment Oral Medicine Sales by Manufacturers (2019-2024)
    • 3.1.2 Global Hepatitis B Treatment Oral Medicine Sales Market Share by Manufacturers (2019-2024)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hepatitis B Treatment Oral Medicine in 2023
  • 3.2 Global Hepatitis B Treatment Oral Medicine Revenue by Manufacturers
    • 3.2.1 Global Hepatitis B Treatment Oral Medicine Revenue by Manufacturers (2019-2024)
    • 3.2.2 Global Hepatitis B Treatment Oral Medicine Revenue Market Share by Manufacturers (2019-2024)
    • 3.2.3 Global Top 10 and Top 5 Companies by Hepatitis B Treatment Oral Medicine Revenue in 2023
  • 3.3 Global Key Players of Hepatitis B Treatment Oral Medicine, Industry Ranking, 2022 VS 2023 VS 2024
  • 3.4 Global Hepatitis B Treatment Oral Medicine Sales Price by Manufacturers
  • 3.5 Analysis of Competitive Landscape
    • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.5.2 Global Hepatitis B Treatment Oral Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.6 Global Key Manufacturers of Hepatitis B Treatment Oral Medicine, Manufacturing Base Distribution and Headquarters
  • 3.7 Global Key Manufacturers of Hepatitis B Treatment Oral Medicine, Product Offered and Application
  • 3.8 Global Key Manufacturers of Hepatitis B Treatment Oral Medicine, Date of Enter into This Industry
  • 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Hepatitis B Treatment Oral Medicine Sales by Type
    • 4.1.1 Global Hepatitis B Treatment Oral Medicine Historical Sales by Type (2019-2024)
    • 4.1.2 Global Hepatitis B Treatment Oral Medicine Forecasted Sales by Type (2025-2030)
    • 4.1.3 Global Hepatitis B Treatment Oral Medicine Sales Market Share by Type (2019-2030)
  • 4.2 Global Hepatitis B Treatment Oral Medicine Revenue by Type
    • 4.2.1 Global Hepatitis B Treatment Oral Medicine Historical Revenue by Type (2019-2024)
    • 4.2.2 Global Hepatitis B Treatment Oral Medicine Forecasted Revenue by Type (2025-2030)
    • 4.2.3 Global Hepatitis B Treatment Oral Medicine Revenue Market Share by Type (2019-2030)
  • 4.3 Global Hepatitis B Treatment Oral Medicine Price by Type
    • 4.3.1 Global Hepatitis B Treatment Oral Medicine Price by Type (2019-2024)
    • 4.3.2 Global Hepatitis B Treatment Oral Medicine Price Forecast by Type (2025-2030)

5 Market Size by Application

  • 5.1 Global Hepatitis B Treatment Oral Medicine Sales by Application
    • 5.1.1 Global Hepatitis B Treatment Oral Medicine Historical Sales by Application (2019-2024)
    • 5.1.2 Global Hepatitis B Treatment Oral Medicine Forecasted Sales by Application (2025-2030)
    • 5.1.3 Global Hepatitis B Treatment Oral Medicine Sales Market Share by Application (2019-2030)
  • 5.2 Global Hepatitis B Treatment Oral Medicine Revenue by Application
    • 5.2.1 Global Hepatitis B Treatment Oral Medicine Historical Revenue by Application (2019-2024)
    • 5.2.2 Global Hepatitis B Treatment Oral Medicine Forecasted Revenue by Application (2025-2030)
    • 5.2.3 Global Hepatitis B Treatment Oral Medicine Revenue Market Share by Application (2019-2030)
  • 5.3 Global Hepatitis B Treatment Oral Medicine Price by Application
    • 5.3.1 Global Hepatitis B Treatment Oral Medicine Price by Application (2019-2024)
    • 5.3.2 Global Hepatitis B Treatment Oral Medicine Price Forecast by Application (2025-2030)

6 US & Canada

  • 6.1 US & Canada Hepatitis B Treatment Oral Medicine Market Size by Type
    • 6.1.1 US & Canada Hepatitis B Treatment Oral Medicine Sales by Type (2019-2030)
    • 6.1.2 US & Canada Hepatitis B Treatment Oral Medicine Revenue by Type (2019-2030)
  • 6.2 US & Canada Hepatitis B Treatment Oral Medicine Market Size by Application
    • 6.2.1 US & Canada Hepatitis B Treatment Oral Medicine Sales by Application (2019-2030)
    • 6.2.2 US & Canada Hepatitis B Treatment Oral Medicine Revenue by Application (2019-2030)
  • 6.3 US & Canada Hepatitis B Treatment Oral Medicine Market Size by Country
    • 6.3.1 US & Canada Hepatitis B Treatment Oral Medicine Revenue by Country: 2019 VS 2023 VS 2030
    • 6.3.2 US & Canada Hepatitis B Treatment Oral Medicine Sales by Country (2019-2030)
    • 6.3.3 US & Canada Hepatitis B Treatment Oral Medicine Revenue by Country (2019-2030)
    • 6.3.4 US
    • 6.3.5 Canada

7 Europe

  • 7.1 Europe Hepatitis B Treatment Oral Medicine Market Size by Type
    • 7.1.1 Europe Hepatitis B Treatment Oral Medicine Sales by Type (2019-2030)
    • 7.1.2 Europe Hepatitis B Treatment Oral Medicine Revenue by Type (2019-2030)
  • 7.2 Europe Hepatitis B Treatment Oral Medicine Market Size by Application
    • 7.2.1 Europe Hepatitis B Treatment Oral Medicine Sales by Application (2019-2030)
    • 7.2.2 Europe Hepatitis B Treatment Oral Medicine Revenue by Application (2019-2030)
  • 7.3 Europe Hepatitis B Treatment Oral Medicine Market Size by Country
    • 7.3.1 Europe Hepatitis B Treatment Oral Medicine Revenue by Country: 2019 VS 2023 VS 2030
    • 7.3.2 Europe Hepatitis B Treatment Oral Medicine Sales by Country (2019-2030)
    • 7.3.3 Europe Hepatitis B Treatment Oral Medicine Revenue by Country (2019-2030)
    • 7.3.4 Germany
    • 7.3.5 France
    • 7.3.6 U.K.
    • 7.3.7 Italy
    • 7.3.8 Russia

8 China

  • 8.1 China Hepatitis B Treatment Oral Medicine Market Size
    • 8.1.1 China Hepatitis B Treatment Oral Medicine Sales (2019-2030)
    • 8.1.2 China Hepatitis B Treatment Oral Medicine Revenue (2019-2030)
  • 8.2 China Hepatitis B Treatment Oral Medicine Market Size by Application
    • 8.2.1 China Hepatitis B Treatment Oral Medicine Sales by Application (2019-2030)
    • 8.2.2 China Hepatitis B Treatment Oral Medicine Revenue by Application (2019-2030)

9 Asia (excluding China)

  • 9.1 Asia Hepatitis B Treatment Oral Medicine Market Size by Type
    • 9.1.1 Asia Hepatitis B Treatment Oral Medicine Sales by Type (2019-2030)
    • 9.1.2 Asia Hepatitis B Treatment Oral Medicine Revenue by Type (2019-2030)
  • 9.2 Asia Hepatitis B Treatment Oral Medicine Market Size by Application
    • 9.2.1 Asia Hepatitis B Treatment Oral Medicine Sales by Application (2019-2030)
    • 9.2.2 Asia Hepatitis B Treatment Oral Medicine Revenue by Application (2019-2030)
  • 9.3 Asia Hepatitis B Treatment Oral Medicine Sales by Region
    • 9.3.1 Asia Hepatitis B Treatment Oral Medicine Revenue by Region: 2019 VS 2023 VS 2030
    • 9.3.2 Asia Hepatitis B Treatment Oral Medicine Revenue by Region (2019-2030)
    • 9.3.3 Asia Hepatitis B Treatment Oral Medicine Sales by Region (2019-2030)
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 China Taiwan
    • 9.3.7 Southeast Asia
    • 9.3.8 India

10 Middle East, Africa and Latin America

  • 10.1 Middle East, Africa and Latin America Hepatitis B Treatment Oral Medicine Market Size by Type
    • 10.1.1 Middle East, Africa and Latin America Hepatitis B Treatment Oral Medicine Sales by Type (2019-2030)
    • 10.1.2 Middle East, Africa and Latin America Hepatitis B Treatment Oral Medicine Revenue by Type (2019-2030)
  • 10.2 Middle East, Africa and Latin America Hepatitis B Treatment Oral Medicine Market Size by Application
    • 10.2.1 Middle East, Africa and Latin America Hepatitis B Treatment Oral Medicine Sales by Application (2019-2030)
    • 10.2.2 Middle East, Africa and Latin America Hepatitis B Treatment Oral Medicine Revenue by Application (2019-2030)
  • 10.3 Middle East, Africa and Latin America Hepatitis B Treatment Oral Medicine Sales by Country
    • 10.3.1 Middle East, Africa and Latin America Hepatitis B Treatment Oral Medicine Revenue by Country: 2019 VS 2023 VS 2030
    • 10.3.2 Middle East, Africa and Latin America Hepatitis B Treatment Oral Medicine Revenue by Country (2019-2030)
    • 10.3.3 Middle East, Africa and Latin America Hepatitis B Treatment Oral Medicine Sales by Country (2019-2030)
    • 10.3.4 Brazil
    • 10.3.5 Mexico
    • 10.3.6 Turkey
    • 10.3.7 Israel
    • 10.3.8 GCC Countries

11 Company Profiles

  • 11.1 GSK
    • 11.1.1 GSK Company Information
    • 11.1.2 GSK Overview
    • 11.1.3 GSK Hepatitis B Treatment Oral Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.1.4 GSK Hepatitis B Treatment Oral Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 GSK Recent Developments
  • 11.2 Bristol Myers Squibb
    • 11.2.1 Bristol Myers Squibb Company Information
    • 11.2.2 Bristol Myers Squibb Overview
    • 11.2.3 Bristol Myers Squibb Hepatitis B Treatment Oral Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.2.4 Bristol Myers Squibb Hepatitis B Treatment Oral Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 Bristol Myers Squibb Recent Developments
  • 11.3 Gilead Sciences
    • 11.3.1 Gilead Sciences Company Information
    • 11.3.2 Gilead Sciences Overview
    • 11.3.3 Gilead Sciences Hepatitis B Treatment Oral Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.3.4 Gilead Sciences Hepatitis B Treatment Oral Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Gilead Sciences Recent Developments
  • 11.4 Novartis
    • 11.4.1 Novartis Company Information
    • 11.4.2 Novartis Overview
    • 11.4.3 Novartis Hepatitis B Treatment Oral Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.4.4 Novartis Hepatitis B Treatment Oral Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 Novartis Recent Developments
  • 11.5 Roche
    • 11.5.1 Roche Company Information
    • 11.5.2 Roche Overview
    • 11.5.3 Roche Hepatitis B Treatment Oral Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.5.4 Roche Hepatitis B Treatment Oral Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 Roche Recent Developments
  • 11.6 Merck
    • 11.6.1 Merck Company Information
    • 11.6.2 Merck Overview
    • 11.6.3 Merck Hepatitis B Treatment Oral Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.6.4 Merck Hepatitis B Treatment Oral Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 Merck Recent Developments
  • 11.7 Johnson & Johnson
    • 11.7.1 Johnson & Johnson Company Information
    • 11.7.2 Johnson & Johnson Overview
    • 11.7.3 Johnson & Johnson Hepatitis B Treatment Oral Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.7.4 Johnson & Johnson Hepatitis B Treatment Oral Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 Johnson & Johnson Recent Developments
  • 11.8 Dawnrays Pharmaceutical
    • 11.8.1 Dawnrays Pharmaceutical Company Information
    • 11.8.2 Dawnrays Pharmaceutical Overview
    • 11.8.3 Dawnrays Pharmaceutical Hepatitis B Treatment Oral Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.8.4 Dawnrays Pharmaceutical Hepatitis B Treatment Oral Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 Dawnrays Pharmaceutical Recent Developments
  • 11.9 Hansoh Pharmaceutical
    • 11.9.1 Hansoh Pharmaceutical Company Information
    • 11.9.2 Hansoh Pharmaceutical Overview
    • 11.9.3 Hansoh Pharmaceutical Hepatitis B Treatment Oral Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.9.4 Hansoh Pharmaceutical Hepatitis B Treatment Oral Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 Hansoh Pharmaceutical Recent Developments
  • 11.10 Chia Tai-Tianqing Pharmaceutical
    • 11.10.1 Chia Tai-Tianqing Pharmaceutical Company Information
    • 11.10.2 Chia Tai-Tianqing Pharmaceutical Overview
    • 11.10.3 Chia Tai-Tianqing Pharmaceutical Hepatitis B Treatment Oral Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.10.4 Chia Tai-Tianqing Pharmaceutical Hepatitis B Treatment Oral Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.10.5 Chia Tai-Tianqing Pharmaceutical Recent Developments
  • 11.11 Qilu pharmaceutical
    • 11.11.1 Qilu pharmaceutical Company Information
    • 11.11.2 Qilu pharmaceutical Overview
    • 11.11.3 Qilu pharmaceutical Hepatitis B Treatment Oral Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.11.4 Qilu pharmaceutical Hepatitis B Treatment Oral Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.11.5 Qilu pharmaceutical Recent Developments
  • 11.12 Fujian Cosunter Pharma
    • 11.12.1 Fujian Cosunter Pharma Company Information
    • 11.12.2 Fujian Cosunter Pharma Overview
    • 11.12.3 Fujian Cosunter Pharma Hepatitis B Treatment Oral Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.12.4 Fujian Cosunter Pharma Hepatitis B Treatment Oral Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.12.5 Fujian Cosunter Pharma Recent Developments
  • 11.13 YaoPharma
    • 11.13.1 YaoPharma Company Information
    • 11.13.2 YaoPharma Overview
    • 11.13.3 YaoPharma Hepatitis B Treatment Oral Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.13.4 YaoPharma Hepatitis B Treatment Oral Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.13.5 YaoPharma Recent Developments
  • 11.14 Qingfeng Pharmaceutical
    • 11.14.1 Qingfeng Pharmaceutical Company Information
    • 11.14.2 Qingfeng Pharmaceutical Overview
    • 11.14.3 Qingfeng Pharmaceutical Hepatitis B Treatment Oral Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.14.4 Qingfeng Pharmaceutical Hepatitis B Treatment Oral Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.14.5 Qingfeng Pharmaceutical Recent Developments
  • 11.15 Kelun Pharmaceutical
    • 11.15.1 Kelun Pharmaceutical Company Information
    • 11.15.2 Kelun Pharmaceutical Overview
    • 11.15.3 Kelun Pharmaceutical Hepatitis B Treatment Oral Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.15.4 Kelun Pharmaceutical Hepatitis B Treatment Oral Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.15.5 Kelun Pharmaceutical Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Hepatitis B Treatment Oral Medicine Industry Chain Analysis
  • 12.2 Hepatitis B Treatment Oral Medicine Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Hepatitis B Treatment Oral Medicine Production Mode & Process
  • 12.4 Hepatitis B Treatment Oral Medicine Sales and Marketing
    • 12.4.1 Hepatitis B Treatment Oral Medicine Sales Channels
    • 12.4.2 Hepatitis B Treatment Oral Medicine Distributors
  • 12.5 Hepatitis B Treatment Oral Medicine Customers

13 Market Dynamics

  • 13.1 Hepatitis B Treatment Oral Medicine Industry Trends
  • 13.2 Hepatitis B Treatment Oral Medicine Market Drivers
  • 13.3 Hepatitis B Treatment Oral Medicine Market Challenges
  • 13.4 Hepatitis B Treatment Oral Medicine Market Restraints

14 Key Findings in The Global Hepatitis B Treatment Oral Medicine Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer